LAB · Standard BioTools Inc.
AI read · Neutral
The AI's read
The cash would give LAB funds, but the sale also removes its mass cytometry business. LAB agreed to a termination fee, partly covered by GMT. Shareholder approval and completion of the Treeline merger are still required. Those points leave no clear change in LAB's outlook.